As of 2024-10-09, the Relative Valuation of Jazz Pharmaceuticals PLC (JAZZ) is 79.78 USD. This relative valuation is based on P/E multiples. With the latest stock price at 107.62 USD, the upside of Jazz Pharmaceuticals PLC based on Relative Valuation is -25.9%.
The range of the Relative Valuation is 48.79 - 175.48 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 27.4x | 17.2x |
| Forward P/E multiples | 15.2x - 19.7x | 15.4x |
| Fair Price | 48.79 - 175.48 | 79.78 |
| Upside | -54.7% - 63.1% | -25.9% |
| Date | P/E |
| 2024-10-08 | 16.83 |
| 2024-10-07 | 16.97 |
| 2024-10-04 | 17.10 |
| 2024-10-03 | 16.98 |
| 2024-10-02 | 17.15 |
| 2024-10-01 | 17.05 |
| 2024-09-30 | 17.42 |
| 2024-09-27 | 17.35 |
| 2024-09-26 | 17.23 |
| 2024-09-25 | 16.87 |
| 2024-09-24 | 17.06 |
| 2024-09-23 | 17.04 |
| 2024-09-20 | 17.32 |
| 2024-09-19 | 17.40 |
| 2024-09-18 | 17.13 |
| 2024-09-17 | 17.44 |
| 2024-09-16 | 17.13 |
| 2024-09-13 | 17.01 |
| 2024-09-12 | 16.65 |
| 2024-09-11 | 16.44 |
| 2024-09-10 | 16.75 |
| 2024-09-09 | 16.65 |
| 2024-09-06 | 16.75 |
| 2024-09-05 | 16.95 |
| 2024-09-04 | 16.99 |
| 2024-09-03 | 17.09 |
| 2024-08-30 | 18.14 |
| 2024-08-29 | 18.08 |
| 2024-08-28 | 18.20 |
| 2024-08-27 | 17.95 |
| 2024-08-26 | 17.87 |
| 2024-08-23 | 17.81 |
| 2024-08-22 | 17.91 |
| 2024-08-21 | 17.88 |
| 2024-08-20 | 17.98 |
| 2024-08-19 | 17.86 |
| 2024-08-16 | 17.35 |
| 2024-08-15 | 17.20 |
| 2024-08-14 | 17.08 |
| 2024-08-13 | 17.46 |
| 2024-08-12 | 16.91 |
| 2024-08-09 | 17.41 |
| 2024-08-08 | 17.66 |
| 2024-08-07 | 17.55 |
| 2024-08-06 | 17.41 |
| 2024-08-05 | 17.45 |
| 2024-08-02 | 17.71 |
| 2024-08-01 | 17.89 |
| 2024-07-31 | 17.24 |
| 2024-07-30 | 17.56 |